RomanoC.Safety and effectiveness of dupilumab in prurigo nodularis. J Investig Allergol Clin Immunol, 2021; 31(2):162–163.
2.
DaJ, AliK, LuK, et al.Off-label use of dupilumab for the treatment of moderate to severe atopic dermatitis in children aged below 6 years of age: a case series. Clin Exp Dermatol, 2021; 47(2):423–425.
3.
HuangAH, WilliamsKA, KwatraSG.Prurigo nodularis: epidemiology and clinical features. J Am Acad Dermatol, 2020; 83(6):1559–1565.
4.
BachertC, MannentL, NaclerioRM, et al.Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial. JAMA, 2016; 315(5):469–479.
5.
ChiricozziA, MaurelliM, GoriN, et al.Dupilumab improves clinical manifestations, symptoms, and quality of life in adult patients with chronic nodular prurigo. J Am Acad Dermatol, 2020; 83(1):39–45.
